Amarin gets boost from AstraZeneca and Acasti's study failures

5 days ago

After fake news attacks, and constant attacks by short sellers, Amarin investors finally woke up to some great news on Monday morning as AstraZeneca​ and Acasti Pharma​​ both announced surprisingly disappointing study results for their fish oil products

Loading...

Email Newsletter Subscription.

Don’t you think it’s about time your (day) job got a bit easier? Us too.

Register today and we’ll add you to our mailing list.

I am a